Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature

J Pharmacol Exp Ther. 1973 Feb;184(2):366-75.
No abstract available

MeSH terms

  • Acetylcholine / pharmacology
  • Angiotensin II / pharmacology
  • Animals
  • Atropine / pharmacology
  • Bradykinin / pharmacology
  • Dose-Response Relationship, Drug
  • Epinephrine / pharmacology
  • Female
  • Hallucinogens / administration & dosage
  • Hallucinogens / pharmacology*
  • Humans
  • In Vitro Techniques
  • Lysergic Acid Diethylamide / pharmacology
  • Mescaline / pharmacology
  • Psilocybin / pharmacology
  • Serotonin / pharmacology
  • Sheep
  • Sympatholytics / pharmacology
  • Tripelennamine / pharmacology
  • Umbilical Arteries / drug effects
  • Umbilical Cord / blood supply
  • Umbilical Cord / drug effects*
  • Umbilical Veins / drug effects
  • Vasoconstrictor Agents / pharmacology*

Substances

  • Hallucinogens
  • Sympatholytics
  • Vasoconstrictor Agents
  • Angiotensin II
  • Psilocybin
  • Serotonin
  • Tripelennamine
  • Atropine
  • Lysergic Acid Diethylamide
  • Acetylcholine
  • Mescaline
  • Bradykinin
  • Epinephrine